(Q42450892)

31 October 2017

title

Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy (English)

1 reference

31 October 2017

Suppressions of chronic glomerular injuries and TGF-β1production by HGF in attenuation of murine diabetic nephropathy (English)

1 reference

https://api.crossref.org/works/10.1152/AJPRENAL.00199.2003

16 March 2024

1 reference

https://api.crossref.org/works/10.1152/AJPRENAL.00199.2003

16 March 2024

author name string

Shinya Mizuno

1

1 reference

31 October 2017

Toshikazu Nakamura

2

1 reference

31 October 2017

language of work or name

1 reference

30 September 2003

1 reference

full work available at URL

31 October 2017

https://www.physiology.org/doi/pdf/10.1152/ajprenal.00199.2003

1 reference

https://api.crossref.org/works/10.1152/AJPRENAL.00199.2003

American Journal of Physiology - Renal Physiology

16 March 2024

published in

1 reference

31 October 2017

volume

286

1 reference

31 October 2017

issue

1

1 reference

31 October 2017

page(s)

F134-43

1 reference

Counteractive effects of HGF on PDGF-induced mesangial cell proliferation in a rat model of glomerulonephritis

31 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00199.2003

Transforming growth factor beta in tissue fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00199.2003

Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00199.2003

Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00199.2003

The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00199.2003

Hepatocyte growth factor may function as a renotropic factor for regeneration in rats with acute renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00199.2003

Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00199.2003

The role of the podocyte in glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00199.2003

Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00199.2003

Molecular cloning and expression of human hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00199.2003

Loss of glomerular function and tubulointerstitial fibrosis: cause or effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00199.2003

Hepatocyte growth factor induces collagenase (matrix metalloproteinase-1) via the transcription factor Ets-1 in human hepatic stellate cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00199.2003

Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00199.2003

Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00199.2003

Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00199.2003

Decreased fibronectin expression in Met/HGF-mediated tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00199.2003

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00199.2003

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00199.2003

Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00199.2003

Systemic administration of naked plasmid encoding hepatocyte growth factor ameliorates chronic renal fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00199.2003

Hemodynamic effects of scatter factor in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00199.2003

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00199.2003

Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00199.2003

Hepatocyte growth factor and the kidney: it is not just for the liver

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1152/AJPRENAL.00199.2003

The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis

16 March 2024

5

1 reference

https://api.crossref.org/works/10.1152/AJPRENAL.00199.2003

Effects of streptozotocin treatment in growth hormone (GH) and GH antagonist transgenic mice

16 March 2024

8

1 reference

https://api.crossref.org/works/10.1152/AJPRENAL.00199.2003

Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria

16 March 2024

9

1 reference

https://api.crossref.org/works/10.1152/AJPRENAL.00199.2003

Myofibroblasts and the progression of diabetic nephropathy

16 March 2024

10

1 reference

https://api.crossref.org/works/10.1152/AJPRENAL.00199.2003

Hepatocyte growth factor counteracts transforming growth factor-beta1, through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5/6 nephrectomized mice.

16 March 2024

15

1 reference

https://api.crossref.org/works/10.1152/AJPRENAL.00199.2003

Hepatocyte growth factor: a regulator of extracellular matrix genes in mouse mesangial cells

16 March 2024

18

1 reference

https://api.crossref.org/works/10.1152/AJPRENAL.00199.2003

Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways

16 March 2024

20

1 reference

https://api.crossref.org/works/10.1152/AJPRENAL.00199.2003

Reciprocal balance of hepatocyte growth factor and transforming growth factor-beta 1 in renal fibrosis in mice

16 March 2024

24

1 reference

https://api.crossref.org/works/10.1152/AJPRENAL.00199.2003

Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy

16 March 2024

25

1 reference

https://api.crossref.org/works/10.1152/AJPRENAL.00199.2003

Potential role of an endothelium-specific growth factor, hepatocyte growth factor, on endothelial damage in diabetes

16 March 2024

26

1 reference

https://api.crossref.org/works/10.1152/AJPRENAL.00199.2003

Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats

16 March 2024

27

1 reference

https://api.crossref.org/works/10.1152/AJPRENAL.00199.2003

Initiation and progression of diabetic nephropathy

16 March 2024

31

1 reference

https://api.crossref.org/works/10.1152/AJPRENAL.00199.2003

Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice

16 March 2024

33

1 reference

https://api.crossref.org/works/10.1152/AJPRENAL.00199.2003

Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation

16 March 2024

36

1 reference

https://api.crossref.org/works/10.1152/AJPRENAL.00199.2003

Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy

16 March 2024

42

1 reference

https://api.crossref.org/works/10.1152/AJPRENAL.00199.2003

Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy

16 March 2024

45

1 reference

https://api.crossref.org/works/10.1152/AJPRENAL.00199.2003

16 March 2024

Identifiers

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/crgq76m6ifeerosrrcid2mix5y

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_crgq76m6ifeerosrrcid2mix5y

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/crgq76m6ifeerosrrcid2mix5y

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/crgq76m6ifeerosrrcid2mix5y

1 reference